Anti-Seizure Drug Discontinuation in Individuals with Epilepsy: Single-Centre Experiences — When, How Long, How?
Author:
Open Access
- 12 January 2026
- journal article
- Published by Futurity Research Publishing in Futurity Medicine
- Vol. 5 (1)
Abstract
Aims: The present study aimed to evaluate seizure recurrence rates after anti-seizure medication (ASM) discontinuation in adults with epilepsy and to identify clinical and treatment-related factors associated with relapse. Study Design: Retrospective observational single-center study. Place and Duration of Study: This study was conducted at the Department of Neurology, Hitit University Faculty of Medicine Hospital. Patient data collected between December 2013 and January 2025 were retrospectively analyzed. Methodology: Adult patients with epilepsy who had been seizure-free for at least 2 years and whose ASM therapy was gradually discontinued under neurologist supervision were included. Only patients with normal neurological examination findings, normal cranial Magnetic Resonance Imaging (MRI), and regular follow-up data were analyzed. Demographic characteristics, age at onset, seizure type, duration of seizure-free period prior to discontinuation, treatment modality (monotherapy vs polytherapy), Electroencephalography (EEG) findings before withdrawal, tapering duration, and seizure recurrence were evaluated. Results: Out of 1,538 epilepsy patient files reviewed, ASM therapy was discontinued in 424 patients (27.6%). The cohort included 189 females (44.6%) and 235 males (55.4%), with a mean age of 46.8±15.2 years. Seizure recurrence occurred in 88 patients (20.8%) either during dose reduction or after complete withdrawal. Recurrence was significantly associated with shorter seizure-free duration, polytherapy, abnormal EEG findings, and shorter tapering periods. Conclusion: ASM discontinuation is a critical stage in epilepsy management and remains a complex clinical decision. Individualized withdrawal strategies considering clinical risk factors may help reduce relapse rates and improve long-term outcomes.Keywords
This publication has 20 references indexed in Scilit:
- Seizure-relapse risk following antiseizure medication withdrawal in children with non-lesional focal epilepsyEpilepsy & Behavior, 2025
- Prediction of the recurrence risk in patients with epilepsy after the withdrawal of antiepileptic drugsEpilepsy & Behavior, 2020
- Rapid versus slow withdrawal of antiepileptic drugsCochrane Database of Systematic Reviews, 2020
- Can electroencephalograms provide guidance for the withdrawal of antiepileptic drugs: A meta-analysisClinical Neurophysiology, 2017
- Risk of seizure relapse after antiepileptic drug withdrawal in adult patients with focal epilepsyEpilepsy & Behavior, 2016
- Rates and predictors of patient-reported cognitive side effects of antiepileptic drugs: An extended follow-upSeizure: European Journal of Epilepsy, 2015
- Cosmetic side effects of antiepileptic drugs in adults with epilepsyEpilepsy & Behavior, 2015
- Prospective study on the withdrawal and reinstitution of antiepileptic drugs among seizure-free patients in west ChinaJournal of Clinical Neuroscience, 2013
- Recurrence risk after withdrawal of antiepileptic drugs in children with epilepsy: A prospective studyEuropean Journal of Paediatric Neurology, 2010
- Discontinuing Antiepileptic Drugs in Children with Epilepsy: A Comparison of a Six-Week and a Nine-Month Taper PeriodNew England Journal of Medicine, 1994